HeartFlow FFR-CTHeartFlowHampshire Hospitals Foundation Trust
…g both tests.E. All patients with CAD-RADS 3 or above underwent HeartFlow FFR-CT.Abstract 29 Figure 16CTCA compared to age groupAbstract 29 Figu…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Sulfasalazine6Tisagenlecleucel6Zonisamide6erlotinib6hydromorphone6oxcarbazepine6Botulinum Toxin A6Calcineurin inhibitors6IL-76MMAE6PD-1 inhibitors6PLEX6Saline6Tezacaftor6abiraterone6anticoagulant6antihypertensive medications6dexketoprofen6oral steroids6phenytoin6sodium bicarbonate6Baclofen6Fluoroquinolone6Itraconazole6PPI6PRAME6Rapamycin6antiseizure medications6mephedrone6n-butyl cyanoacrylate6renin-angiotensin system inhibitors6Beta blocker6Entecavir6Oral corticosteroids6Valganciclovir6anti-seizure medications6cabotegravir/rilpivirine6citalopram6dextran sulfate sodium6penicillins6stimulants6teicoplanin6HRT5Treprostinil5Glimepiride5Orlistat5NKTR-2555Emicizumab5Efgartigimod5Sarilumab5Etrasimod5CAB-LA5D-Dimer5GDF-155TMZ5TAF5Darolutamide5ESPB5Marijuana53TC5
Articles mentioning drugs
10,506 articles · page 224 of 876pembrolizumabatezolizumabdurvalumabosimertinibchemoradiotherapyNSCLCnon-small cell lung cancerstage II-III NSCLC
…after surgery, neoadjuvant nivolumab prior to surgery, adjuvant pembrolizumab and atezolizumab after surgery, perioperative durvalumab and pe…
FilgotinibFILUlcerative ColitisNCT05817942
…Background Filgotinib (FIL) is an oral, once-daily, Janus kinase 1 preferential inhib…
vancomycinMDRD
…lusions The CG formula provides the most accurate prediction of vancomycin Cmin. In patients with eGFR <60 mL/min and aged 46–75 years, MD…
tirzepatidedulaglutidesemaglutideGLP-1 RAschronic pancreatitistype 2 diabetesTriNetX US Collaborative NetworkChronic pancreatitis (CP)endoscopic pancreatic interventionsendoscopic pancreatic interventions
…horts: those prescribed GLP-1 RAs (dulaglutide, semaglutide, or tirzepatide) and a control group with no exposure to GLP-1-based therapies.…
99.7%
filgotinibUCEdinburgh IBD UnitproctitisHerpes Zosterrecombinant zoster vaccination
…ilar era, where cost-effectiveness impacts therapeutic choices, filgotinib is an attractive option for UC. Whilst pivotal trial data and s…
99.3%
AdalimumabTofacitinibGolimumabInfliximabVedolizumabUstekinumabulcerative colitisIBDIBD-UCrohn’s disease+1 more
…e primary outcome was the association between time to first AT (Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab or Tofacitinib…
infliximabIFXmelanomaIBDcancer
…hose receiving systemic corticosteroids (cs), 57.5% (n=61) with infliximab (IFX) and 83% (n=45) receiving topical steroids.No infections o…
TirzepatideLiraglutideGLP-1 RAsSemaglutidediabetes
…s demonstrated that demographic factors, BMI, type of GLP-1 RA (Tirzepatide, Semaglutide and Liraglutide), indication and the presence of d…
baclofenTCAtricyclic antidepressantNissen FundoplicationRumination Syndrome
… augmentation, 16/33 (48%) received a TCA, 11/33 (33%) received baclofen, 13/33 (39%) had oesophageal manometry guided biofeedback, 17/3…
lactuloseatopic dermatitissmall intestinal bacterial overgrowthantibioticsNCT05122520
…after 60 minutes to define excessive intestinal fermentation on lactulose breath test. These findings suggest intestinal dysbiosis may pl…
Linezolidsulfamethoxazole/trimethoprimSMX/TMPlung adenocarcinomaNocardia cyriacigeorgicaantibiotic treatment
…ntibiotic, but it can cause side effects, such as liver damage. Linezolid is another valid alternative.Pharmacokinetic monitoring of line…